Online inquiry

IVTScrip™ mRNA-Human ARMC8, (Cap 0, 5-Methyl-CTP & Pseudo-UTP, 120 nt-poly(A))   (CAT#: GTTS-WK23257MR)

This product GTTS-WK23257MR is a type of mRNA having 120 nt poly(A) tail and modified with Cap 0 & 5-Methyl-CTP & Pseudo-UTP. It ecodes the ARMC8 protein. This product can be used in Meiotic prophase fetal germ cell-related researches.
Specifications
Product type mRNA
Modified bases 5-Methyl-CTP & Pseudo-UTP
5' Cap Cap 0
Species Human
RefSeq NM_001267041.2
Applications Gene therapy research
Format Powder
Quantity 100 µg
Purification Chromatography
Target Gene
Gene ID 25852
UniProt ID Q8IUR7
Download
Download resources about mRNA therapeutics development to boost your research.
CUSTOMER REVIEWS and Q&As

There are currently no Customer reviews or questions for IVTScrip™ mRNA-Human ARMC8, (Cap 0, 5-Methyl-CTP & Pseudo-UTP, 120 nt-poly(A)) (GTTS-WK23257MR). Click the button above to contact us or submit your feedback about this product.

See other products
CAT Product Name Product Type CDs
GTTS-WK23551MR IVTScrip™ mRNA-Human ARL8B, (Cap 0, Pseudo-UTP, 30 nt-poly(A)) mRNA ARL8B
GTTS-WK28296MR IVTScrip™ mRNA-Human ARHGAP32, (Cap 1, 5-Methyl-CTP, 30 nt-poly(A)) mRNA ARHGAP32
GTTS-WK7782MR IVTScrip™ mRNA-Human AFF1, (Cap 0, N1-Methylpseudo-UTP, 120 nt-poly(A)) mRNA AFF1
GTTS-WK12806MR IVTScrip™ mRNA-Human ADAMTS7, (Cap 1, Pseudo-UTP, 30 nt-poly(A)) mRNA ADAMTS7
GTTS-WK16660MR IVTScrip™ mRNA-Human AMPH, (Cap 0, N1-Methylpseudo-UTP, 30 nt-poly(A)) mRNA AMPH
GTTS-WK9202MR IVTScrip™ mRNA-Human ADAMTS2, (Cap 0, Pseudo-UTP, 30 nt-poly(A)) mRNA ADAMTS2
GTTS-WK25587MR IVTScrip™ mRNA-Human ARHGAP21, (Cap 1, N1-Methylpseudo-UTP, 120 nt-poly(A)) mRNA ARHGAP21
GTTS-WK28306MR IVTScrip™ mRNA-Human ARHGEF1, (Cap 1, 5-Methyl-CTP, 30 nt-poly(A)) mRNA ARHGEF1
All products and services are For Research Use Only and CANNOT be used in the treatment or diagnosis of disease.
×

Webinar Register

Simone Pinto Carneiro, Ph.D.

Group Leader, Ludwig-Maximilians-University of Munich

date-time 10 AM EDT | May 19, 2026

Register Now →